Clinical Report: Microparticle-Based Oral Vaccine Strategy Utilizing Polysaccharides

Overview

This study evaluates the efficacy of alginate-chitosan microparticles containing a recombinant GnRH-fusion protein (GF45) for immunocastration in male rats. Results indicate significant reductions in testosterone levels and testicular size, suggesting a promising oral vaccination strategy.

Background

Immunocastration via vaccination against GnRH offers a humane alternative to surgical castration in animal production. Oral delivery of protein antigens is challenging due to degradation in the gastrointestinal tract, making effective vaccine delivery critical for animal welfare and production efficiency.

Data Highlights

Key Findings

• Oral administration of GF45 resulted in a 95% reduction in circulating testosterone levels.
• Anti-GF45 antibody response reached 88.8% of the injectable response.
• Seroconversion occurred by week 6, with 100% seroconversion by week 16.
• Testis weight decreased by 52% and volume by 75% following oral vaccination.
• Histological examination showed significant seminiferous-tubule atrophy.

Clinical Implications

The findings suggest that alginate-chitosan microparticles can effectively deliver GnRH-targeting antigens orally, potentially improving immunocastration methods in veterinary practice. This approach may reduce the need for invasive procedures and enhance animal welfare.

Conclusion

Alginate-chitosan microparticles represent a viable oral vaccination platform for immunocastration, demonstrating significant efficacy in reducing testosterone and testicular size in male rats.

Related Resources & Content

1. The Journal of Infectious Diseases, 2022 -- Evaluation of Immunization Route in Induction of Vaccine-Mediated Anti-Gonococcal Immune Responses in a Murine Model of Ascending Infection
2. The Journal of Infectious Diseases, 2023 -- A Chimeric Peptide Vaccine Targeting Plasmodium Circumsporozoite Protein and Mosquito Salivary AgTRIO for Malaria Prevention
3. Acta Neuropathologica, 2021 -- Vaccination with UB-312 in Thy1SNCA Mice Mitigates Motor Impairments and Reduces Oligomeric α-Synuclein Levels in the Brain and Gut
4. 21 CFR § 522.1083 - Gonadotropin releasing factor analog-diphtheria toxoid conjugate. | Electronic Code of Federal Regulations (e-CFR) | US Law | LII / Legal Information Institute
5. Welfare of pigs on farm | EFSA
6. Frontiers in Immunology — Bivalent virus-like particles expressing SPECT1 and CSP trigger pre-erythrocytic malaria immunity and protect against transgenic Plasmodium falciparum sporozoite challenge in mice
7. NWRC Research: Population Management/Reproductive Control
8. Advances and future applications of immunocastration techniques: a comprehensive review
9. 21 CFR § 522.1083 - Gonadotropin releasing factor analog-diphtheria toxoid conjugate. | Electronic Code of Federal Regulations (e-CFR) | US Law | LII / Legal Information Institute
10. Welfare of pigs on farm | EFSA
11. Carcass quality of immunocastrated boars – A retrospective analysis of slaughterhouse data
12. Sustained multi-year contraceptive efficacy of single-dose GonaCon in synanthropic female capybaras - PubMed
13. Modulation of oral vaccine efficacy by the gut microbiota | npj Vaccines
14. Strategies for overcoming multiple barriers of oral administration of protein and peptide therapeutics - ScienceDirect
15. Oral delivery of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in alginate spheres to captive white-tailed deer | BMC Veterinary Research | Springer Nature Link